Skip to main content

Animations

MJFF Publications

6881 - 6890 of 8808 Results
Title
Year
  • Year
  • 2016
  • 2016
  • 2018
  • 2016
  • 2015
  • 2020
  • 2025
  • 2020
  • 2009
  • 2019
  • Summary Details
    OPEN
    Title: Weighted Protein Interaction Network Analysis of Frontotemporal Dementia
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.6b00934
    Citation Count: 41
  • Summary Details
    RESTRICTED
    Title: Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor–Nuclear Receptor Related 1 Protein Dimer Activation
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b01702
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Detection of alpha‐synuclein conformational variants from gastro‐intestinal biopsy tissue as a potential biomarker for Parkinson's disease
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/nan.12486
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease Severity
    Journal Name: Oxidative Medicine and Cellular Longevity
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2016/9409363
    Citation Count: 82
  • Summary Details
    OPEN
    Title: The Discovery of Central Nervous System Lymphatic Vessels: The Missing Link That Closes the Circle of Brain Immunosurveillance
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12282
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25897
    Citation Count: 87
  • Summary Details
    OPEN
    Title: Disruption of the cerebrospinal fluid–plasma protein balance in cognitive impairment and aging
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41591-025-03831-3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.07.022
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3181c29356
    Citation Count: 408
  • Summary Details
    OPEN
    Title: Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.196
    Citation Count: 39
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.